- Home
- Protocols and Guidelines
- Cancer Protocol Templates
Cancer Protocol Templates
The CAP Cancer Reporting Protocols provide guidelines for collecting the essential data elements for complete reporting of malignant tumors and optimal patient care.
The CAP Biomarker Reporting Protocols are intended to provide reporting guidance for commonly ordered biomarkers and are not required for accreditation purposes.
Latest News
- Open all
- Close all
The College of American Pathologists March 2022 release updated 19 CAP Cancer Protocols.
Highlights of these content changes include:
- NEW Protocol – Phyllodes Tumor of the Breast
- All Pediatric Biopsy and Resection Protocols have an added question for Expert Consultation; for Wilms Tumor resection, this change affects the accreditation date
- Deprecated the Distance from Tumor to Vascular, Ureteral, and Soft Tissue Margin Questions for Wilms Tumor Resection: this change affects the accreditation date
- Lymphovascular Invasion was changed from an optional to a core element in the Breast Invasive Resection template which affects the accreditation date
- Clarified Number of Isolated Tumor Cells in the Uterine Sarcoma Resection template which affects the accreditation date
- Other minor content changes include explanatory note updates, corrections of typographical errors, and clarification of answer choices for peritoneal ascitic fluid
All changes are outlined in the Summary of Revisions [under Resources]
The College of American Pathologists November 2021 release updated 19 CAP Cancer Protocols. Highlights of these content changes include:
- Changed the name of the Lip and Oral Cavity to Oral Cavity to update scope of the protocol
- Added ITC reporting question and answer set to Regional Lymph Nodes in Uterus Sarcoma – will affect accreditation date
- Changed nested Margin questions from Conditional to Required and Remodeled Preexisting pleomorphic adenoma component question in Head and Neck Protocols
- Updated Not Applicable statement to state "invasive melanoma" vs "invasive carcinoma" and cover page to qualify use for Invasive Melanoma Excision
- Added a new, repeating section for other user entered biomarkers in Quantitative IHC Biomarker Reporting
- Updated instructional and explanatory notes
- Reformatted Questions and Answers, and reporting order of elements
There are no new or retired protocols in this release. Additionally, there were 13 protocols that underwent technical changes only to their corresponding CAP eCC template. Although these protocols did not have any content changes, they received new version numbers to reconcile our database.
All changes are outlined in the Summary of Revisions [under Resources]
We have scheduled a November 2021 a CAP Cancer Protocols release. It will include content changes to 11 CAP Cancer Protocols. There will be additional metadata changes to 16 CAP electronic Cancer Checklists (CAP eCC) templates.
We will detail all changes in the release documentation and on this page once released.
The WHO Classification of Tumours editorial board recently started writing the Haematolymphoid tumours volume. In an attempt to engage the community further, and in line with International Agency for Research on Cancer’s open science policy, WHO has published for the first time the draft classification for the Haematolymphoid volume with a dedicated email address for comments and suggestions on content to haematolymphoidtumours@iarc.fr. Haematopathologists, haematologists, oncologists, geneticists, molecular pathologists, other cancer specialists, and patient representative are serving as experts. Please submit feedback by October 15, 2021.
- Skin, Melanoma, Biopsy v4.3.0.1 – Updated August 17, 2021
- Updated formatting and added instructional note to better differentiate in situ vs. invasive reporting elements *
- Skin, Melanoma, Resection v4.3.0.1 – Updated August 17, 2021
- Updated formatting and added instructional note to better differentiate in situ vs. invasive reporting elements *
- Ovary, Fallopian Tube, Peritoneum v1.3.0.0 – Updated August 11, 2021
- Corrected staging classifications for pT1a and pT1b
* These are navigational notes for the Cancer Paper Protocols only not for the electronic Cancer Checklist
- Bone, Resection Protocol v4.1.1.0 – Updated July 28, 2021
- Fixed incorrect staging classification for pT1 under pT Category for Appendicular Skeleton, Trunk, Skull, and Facial Bones
- Fixed incorrect staging classification for pT1a under pT Category for Pelvis
- Pancreas (Exocrine) Protocol v4.2.0.1 – Updated July 28, 2021
- Fixed incorrect staging classification note for pT1
- Fixed incorrect staging classification for pT2
- Vulva Protocol v4.2.0.1 – Updated July 28, 2021
- Fixed incorrect staging classification note for pN2
- Lip and Oral Cavity Protocol v4.1.0.1 – Updated July 28, 2021
- Fixed error in All Carcinomas - pT Category - pT1
- Fixed error in All Carcinomas - pT Category - pT4a
- Stomach Resection Protocol v4.2.1.0 – Updated July 27, 2021
- Added back "pM1: Distant metastasis" Answer
- Uterine Cervix Resection Protocol v5.0.1.1 – Updated July 16, 2021
- Added “Other (specify)” as answer options to Para-aortic Lymph Node questions
The College of American Pathologists (CAP) June 2021 release of the updated CAP Cancer Protocols, includes 87 revised and three new cancer protocols.
Highlights of the changes in this release include:
- New WHO histologic codes for the Bone / Soft Tissue, Gynecologic, and Thorax protocols
- Removed pTX and pNX staging
- Added new Distant Metastasis sections
- Updated modeling standard for margin sections across all protocols
- Updated modeling standard for lymph node sections across all protocols
- Protocol format standardization resulting from new authoring process
- Replaced all symbols (<,>,<=,>=) with actual words less than, greater than, etc.
Along with the above noted changes, we also released three NEW Cancer Reporting Protocols.
- Prostate Needle Biopsy (Case Level) Protocol
- Prostate Needle Biopsy (Specimen Level) Protocol
- Quantitative IHC Reporting Protocol
Notes: None of the new protocols are required for Accreditation and no
Cancer Protocols have been retired in this release.
Paperback Option for AJCC Cancer Staging System: Cervix Uteri Protocol Version 9
The American Joint Committee on Cancer (AJCC) received important feedback from the College of American Pathologists and our members as well as cancer registry and clinical communities regarding the AJCC Cancer Staging System: Cervix Uteri Protocol (Version 9), released as an eBook in October 2020. AJCC learned from users that the Version 9 eBook format was not sufficient and they wanted the information in print form as institutional firewalls was blocking the content, in many instances. AJCC is still evaluating all options for disseminating AJCC content and recently announced that a paperback version of AJCC Cancer Staging System: Cervix Uteri Protocol (Version 9) is now available for purchase on Amazon for $9.99. Learn more
The College of American Pathologists October 28, 2020 Uterine Cervix release includes 2 revised cancer protocols. Highlights include:
- Addition of “Equivocal” to Lymphovascular Invasion
- Margins Section modifications
- Addition of a separate Distant Metastasis section
- Revisions to the Lymph Node Section (driven by new AJCC pN Staging Classification)
- Updates to AJCC 9th Version pTNM Staging Classification including alternate verbiage in lieu of pTX and pNX as approved by AJCC
- Updates to include FIGO 2018 Staging Corrigendum (for more information, see https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/ijgo.12969)
- Updates to Explanatory Notes for Histologic Type, Silva Pattern, Lymphovascular Invasion
- General formatting changes
- Public Comments received are available.
The AJCC has set an implementation date of January 1, 2021 for use of the 9th Version of its Uterine Cervix cancer staging system. Users should ensure that they update their cancer reporting systems for the Uterine Cervix Resection protocol prior to the January 1, 2021 implementation date.
- Read the cancer protocol frequently asked questions.
- Download the definition of Synoptic Reporting With Examples.
- Visit the cancer protocol resources webpage to read about current issues with units of measurements.
- Integrate the Cancer Protocol & Biomarker Templates into your LIS workflow. Learn about our eCC (electronic Cancer Checklists) and eFRM (electronic Forms and Reporting Module)
- Download a compressed file containing all of current CAP cancer protocols.
- Download the current summary of revisions.
- Download the summary of required elements.
- Provide your feedback about the CAP cancer protocols to cprotoc@cap.org.
- June 2021 news release.
Current and previous cancer reporting and biomarker reporting protocols can be downloaded using the links in the table below.
Cancer Reporting and Biomarker Reporting Protocols
2013-2018 Previous Versions Are Available Upon Request
Breast
Breast DCIS, Resection | Previous Version 2020 (v4.3.0.2) 2019 (v4.3.0.1) 2019 (v4.3.0.0) 2019 (v4.2.0.0) |
|
Breast DCIS, Biopsy | Current Version PDF (v1.0.1.0) Word (v1.0.1.0) June 2021 |
Previous Version 2020 (v1.0.0.1) 2019 (v1.0.0.0) |
Breast Phyllodes Tumor *NEW* | Current Version PDF (v1.0.0.0) Word (v1.0.0.0) March 2022 |
Previous Version n/a |
Breast Invasive, Resection | Current Version PDF (v4.6.0.0) Word (v4.6.0.0) March 2022 |
Previous Version 2021 (v4.5.0.1) 2021 (v4.5.0.0) 2020 (v4.4.0.0) 2019 (v4.3.0.1) |
Breast Invasive, Biopsy | Current Version PDF (v1.1.1.1) Word (v1.1.1.1) November 2021 |
Previous Version 2021 (v1.1.1.0) 2020 (v1.1.0.0) 2019 (v1.0.0.1) 2019 (v1.0.0.0) |
Breast Biomarker Reporting | Current Version PDF (v1.4.1.1) Word (v1.4.1.1) November 2021 |
Previous Version 2021 (v1.4.1.0) 2020 (v1.4.0.0) 2019 (v1.3.0.0) |
Central Nervous System
Endocrine
Adrenal Gland | Current Version PDF (v4.2.1.0) Word (v4.2.1.0) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.0) 2019 (v4.0.2.0) |
Appendix NET | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.0.2) |
Colon NET | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.0.2) |
Duodenum and Ampulla NET | Current Version PDF (v1.1.0.0) Word (v1.1.0.0) June 2021 |
Previous Version 2020 (v1.0.0.2) |
Jejunum and Ileum NET | Current Version PDF (v1.1.0.0) Word (v1.1.0.0) June 2021 |
Previous Version 2020 (v1.0.0.1) |
Pancreas (Endocrine) | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.0.2) |
Stomach NET | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.0.2) |
Thyroid | Current Version PDF (v4.3.0.0) Word (v4.3.0.0) June 2021 |
Previous Version 2020 (v4.2.0.0) 2019 (v4.1.0.0) |
Thyroid Biomarker Reporting | Current Version PDF (v1.0.0.1) Word (v1.0.0.1) June 2016 |
Previous Version 2015 (v1.0.0.0) |
Gastrointestinal
Ampulla of Vater | Current Version PDF (v4.2.0.1) Word (v4.2.0.1) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.0) |
Anus, Excision | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.1) 2020 (v4.1.0.0) |
Anus, Resection | Current Version PDF (v4.2.0.1) Word (v4.2.0.1) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.0) |
Appendix | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Colon and Rectum, Biopsy | Current Version PDF (v4.2.0.1) Word (v4.2.0.1) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.0) |
Colon and Rectum, Resection | Current Version PDF (v4.2.0.1) Word (v4.2.0.1) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.0) |
Colon and Rectum Biomarker Reporting | Current Version PDF (v1.3.0.0) Word (v1.3.0.0) June 2021 |
Previous Version 2014 (v1.2.0.1) |
Distal Extrahepatic Bile Ducts | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Esophagus | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Gallbladder | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
GIST, Biopsy | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
GIST, Resection | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
GIST Biomarker Reporting | Current Version PDF (v1.0.0.2) Word (v1.0.0.2) February 2020 |
Previous Version 2015 (v1.0.0.1) 2014 (v1.0.0.0) |
Hepatocellular Carcinoma | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Intrahepatic Bile Ducts | Current Version PDF (v4.2.0.0) Word(v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Pancreas (Exocrine) | Current Version PDF (v4.2.0.2) Word (v4.2.0.2) November 2021 |
Previous Version 2021 (v4.2.0.1) 2021 (v4.2.0.0) 2020 (v4.1.0.0) |
Perihilar Bile Ducts | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Small Intestine | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) June 2021 |
Previous Version 2020 (v4.1.0.0) |
Stomach | Current Version PDF (v4.2.1.0) Word (v4.2.1.0) July 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.0) |
Gastric HER2 Biomarker Reporting | Current Version PDF (v1.0.0.1) Word (v1.0.0.1) June 2017 |
Previous Version 2014 (v1.0.0.0) |
Genitourinary
Kidney, Biopsy | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.2.0) |
Kidney, Resection | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.2.0) |
Penis | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2017 (v4.0.1.0) |
Prostate Needle Biopsy Case Level | Current Version PDF (1.0.0.1) Word (1.0.0.1) November 2021 | Previous Version 2021 (1.0.0.0) |
Prostate Needle Biopsy Specimen Level | Current Version PDF (1.0.0.1) Word(1.0.0.1) November 2021 | Previous Version 2021 (1.0.0.0) |
Prostate, Resection | Current Version PDF (v4.2.0.1) Word (v4.2.0.1) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020(v4.1.0.1) 2019 (v4.0.4.1) 2019 (v4.0.4.0) |
Prostate TURP | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.5.0) 2019 (v4.0.4.1) |
Testis Radical Orchiectomy | Current Version PDF (v4.1.0.1) Word(v4.1.0.1) November 2021 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.1.2) |
Testis Lymphadenectomy | Current Version PDF (v4.1.0.1) Word (v4.1.0.1) November 2021 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.1.1) |
Ureter, Renal Pelvis, Biopsy | Current Version PDF (v2.2.0.0) Word (v2.2.0.0) June 2021 |
Previous Version 2019 (v2.1.0.0) |
Ureter, Renal Pelvis, Resection | Current Version PDF (v2.2.0.0) Word (v2.2.0.0) June 2021 |
Previous Version 2019 (v2.1.0.0) |
Urethra, Biopsy | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2019 (v4.0.2.0) |
Urethra, Resection | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.3.0) 2019 (v4.0.2.0) |
Urinary Bladder, Resection | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.2.0) 2019 (v4.0.1.1) |
Urinary Bladder, Biopsy | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.2.0) 2019 (v4.0.1.1) |
Gynecologic
Endometrium Uterus | Current Version PDF (v4.2.0.2) Word(v4.2.0.2) March 2022 |
Previous Version 2021 (v4.2.0.1) 2021 (v4.2.0.0) 2020 (v4.1.0.2) 2019 (v4.1.0.1) |
Endometrium Biomarker Reporting | Current Version PDF (v1.2.0.1) Word (v1.2.0.1) September 2019 |
Previous Version 2019 (v1.2.0.0) 2016 (v1.1.0.0) 2015 (v1.0.0.0) |
Ovary, Fallopian Tube, or Peritoneum | Current Version PDF(v1.3.0.2) Word (v1.3.0.2) March 2022 |
Previous Version 2021 (v1.3.0.1) 2021 (v1.3.0.0) 2020 (v1.1.1.0) |
Trophoblastic Tumors | Current Version PDF (v4.1.0.1) Word (v4.1.0.1) November 2021 |
Previous Version 2021 (v4.1.0.0) 2017 (v4.0.0.0) |
Uterine Cervix, Excision | Current Version PDF (v4.4.1.0) Word (v4.4.1.0) June 2021 |
Previous Version 2020 (v4.4.0.0) 2020 (v4.3.0.0) 2019 (v4.2.0.0) |
Uterine Cervix, Resection | Current Version PDF (v5.0.1.3) Word (v5.0.1.3) March 2022 |
Previous Version 2021(v5.0.1.2) 2021 (v5.0.1.1) 2021 (v5.0.1.0) 2020 (v5.0.0.0) 2020 (v4.3.0.0) |
Uterine Sarcoma | Current Version PDF (v4.4.0.0) Word (v4.4.0.0) March 2022 |
Previous Version 2021 (v4.3.0.0) 2021 (v4.2.0.0) 2018 (v4.1.0.0) |
Vagina, Biopsy | Current Version PDF (v4.3.0.0) Word (v4.3.0.0) June 2021 |
Previous Version 2019 (v4.2.0.0) |
Vagina, Resection | Current Version PDF (v4.3.0.1) Word(v4.3.0.1) November 2021 |
Previous Version 2021 (v4.3.0.0) 2020 (v4.2.0.1) 2019 (v4.2.0.0) |
Vulva | Current Version PDF (v4.2.0.2) Word (v4.2.0.2) November 2021 |
Previous Version 2021 (v4.2.0.1) 2021 (v4.2.0.0) 2020 (v4.1.0.1) |
Head and Neck
Larynx | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) November 2021 |
Previous Version 2021 (v4.1.0.0) 2017 (v4.0.0.1) |
Oral Cavity | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) November 2021 |
Previous Version 2021 (v4.1.0.1) 2021 (v4.1.0.0) 2017 (v4.0.0.1) |
Major Salivary Glands | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) November 2021 |
Previous Version 2021 (v4.1.0.0) 2017 (v4.0.0.1) |
Nasal Cavity and Paranasal Sinuses | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) November 2021 |
Previous Version 2021 (v4.1.0.0) 2017 (v4.0.0.1) |
Pharynx | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) November 2021 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.2) |
Head and Neck Biomarker Reporting | Current Version PDF (v2.0.0.1) Word (v2.0.0.1) November 2021 |
Previous Version 2021 (v2.0.0.0) 2017 (v1.0.0.0) |
Hematologic
Bone Marrow | Current Version PDF (v4.0.0.0) Word (v4.0.0.0) February 2019 |
Previous Version 2018 (v3.1.0.0) 2017 (v3.0.1.2) 2012 (v3.0.1.1) |
Hodgkin Lymphoma | Current Version PDF (v3.1.0.1) Word (v3.1.0.1) October 2013 |
Previous Version 2013 (v3.1.0.0) |
Non-Hodgkin Lymphoma | Current Version PDF (v3.2.0.1) Word (v3.2.0.1) October 2013 |
Previous Version 2013 (v3.2.0.0) |
Plasma Cell Neoplasms | Current Version PDF (v1.0.0.2) Word (v1.0.0.2) January 2015 |
Previous Version 2015 (v1.0.0.1) 2015 (v1.0.0.0) |
Ophthalmic
Pediatric
Ewing, Resection | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Ewing, Biopsy | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Germ Cell Tumor, Resection | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Germ Cell Tumor, Biopsy | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Hepatoblastoma, Resection | Current Version PDF (v4.0.2.0) Word (v4.0.2.0) March 2022 |
Previous Version 2021 (v4.0.1.0) 2019 (v4.0.0.0) |
Hepatoblastoma, Biopsy | Current Version PDF (v4.0.1.0) Word (v4.0.1.0) March 2022 |
Previous Version 2021 (v4.0.0.1) 2019 (v4.0.0.0) |
Neuroblastoma, Resection | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Neuroblastoma, Biopsy | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Rhabdomyosarcoma, Resection | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Rhabdomyosarcoma, Biopsy | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Wilms, Resection | Current Version PDF (v4.2.0.0) Word (v4.2.0.0) March 2022 |
Previous Version 2021 (v4.1.0.0) 2019 (v4.0.0.0) |
Wilms, Biopsy | Current Version PDF (v4.0.1.0) Word (v4.0.1.0) March 2022 |
Previous Version 2021 (v4.0.0.1) 2019 (v4.0.0.0) |
Skin
Skin, Melanoma, Biopsy | Current Version PDF (v4.3.1.0) Word (v4.3.1.0) March 2022 |
Previous Version 2021 (v4.3.0.1) 2021 (v4.3.0.0) 2020 (v4.2.0.0) 2020 (v4.1.1.0) 2019 (v4.1.0.0) |
Skin, Melanoma, Excision | Current Version PDF (v4.3.0.2) Word (v4.3.0.2) November 2021 |
Previous Version 2021 (v4.3.0.1) 2021 (v4.3.0.0) 2020 (v4.2.0.0) 2020 (v4.1.0.0) |
Melanoma Biomarker Reporting | Current Version PDF (v1.0.0.2) Word (v1.0.0.2) July 2015 |
Previous Version 2015 (v1.0.0.1) 2015 (v1.0.0.0) |
Merkel Cell Carcinoma | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2017 (v4.0.0.1) |
Thorax
Lung, Resection | Current Version PDF (v4.2.0.1) Word (v4.2.0.1) November 2021 |
Previous Version 2021 (v4.2.0.0) 2020 (v4.1.0.1) 2019 (v4.1.0.0) |
Lung Biomarker Reporting | Current Version PDF (v2.0.1.0) Word (v2.0.1.0) November 2021 |
Previous Version 2021 (v2.0.0.0) 2016 (v1.3.0.2) |
Pleural Mesothelioma | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2017 (v4.0.0.1) |
Thymus | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2017 (v4.0.0.1) |
Bone and Soft Tissue
Bone, Biopsy | Current Version PDF (v4.1.0.1) Word (v4.1.0.1) November 2021 |
Previous Version 2021 (v4.1.0.0) 2020 (v4.0.1.0) |
Bone, Resection | Current Version PDF (v4.1.1.0) Word (v4.1.1.0) July 2021 |
Previous Version 2021 (v4.1.0.0) 2020 (v4.0.1.0) |
Soft Tissue, Biopsy | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.2.0) 2019 (v4.0.1.1) |
Soft Tissue, Resection | Current Version PDF (v4.1.0.0) Word (v4.1.0.0) June 2021 |
Previous Version 2020 (v4.0.2.0) 2019 (v4.0.1.1) |
General
DNA Mismatch Repair Biomarker Reporting | Current Version PDF (v1.0.0.2) Word (v1.0.0.2) June 2021 |
Previous Version 2018 (v1.0.0.0) |
Generic Template, Biopsy | Current Version PDF (v1.0.1.0) Word (v1.0.1.0) June 2021 |
Previous Version 2019 (v1.0.0.0) |
Generic Template, Resection | Current Version PDF (v1.1.0.0) Word (v1.1.0.0) June 2021 |
Previous Version 2019 (v1.0.0.0) |
General IHC Quantitative Biomarkers | Current Version PDF (1.1.0.0) Word (1.1.0.0) November 2021 | Previous Version 2021 (1.0.0.0) |
CAP Cancer Protocol Usage Limitations and Copyright
© 2021 College of American Pathologists (CAP). All rights reserved.
The College of American Pathologists (CAP) does not permit reproduction of any substantial portion of these protocols without its written authorization. The CAP hereby authorizes use of these protocols by physicians and other health care providers in reporting on surgical specimens, in teaching, and in carrying out medical research for nonprofit purposes. This authorization does not extend to reproduction or other use of any substantial portion of these protocols for commercial purposes without the written consent of the CAP.
The CAP also authorizes physicians and other health care practitioners to make modified versions of the Protocols solely for their individual use in reporting on surgical specimens for individual patients, teaching, and carrying out medical research for non-profit purposes.
The CAP further authorizes the following uses by physicians and other health care practitioners, in reporting on surgical specimens for individual patients, in teaching, and in carrying out medical research for non-profit purposes: (1) Dictation from the original or modified protocols for the purposes of creating a text-based patient record on paper, or in a word processing document; (2) Copying from the original or modified protocols into a text-based patient record on paper, or in a word processing document; (3) The use of a computerized system for items (1) and (2), provided that the protocol data is stored intact as a single text-based document, and is not stored as multiple discrete data fields.
Other than uses (1), (2), and (3) above, the CAP does not authorize any use of the Protocols in electronic medical records systems, pathology informatics systems, cancer registry computer systems, computerized databases, mappings between coding works, or any computerized system without a written license from the CAP.
Any public dissemination of the original or modified protocols is prohibited without a written license from the CAP.
The Protocols include tumor staging data used with permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2020).
The CAP developed these protocols as an educational tool to assist pathologists in the useful reporting of relevant information. It did not issue the protocols for use in litigation, reimbursement, or other contexts. Nevertheless, the CAP recognizes that the protocols might be used by hospitals, attorneys, payers, and others. Indeed, effective January 1, 2004, the Commission on Cancer of the American College of Surgeons mandated the use of the required data elements of the protocols as part of its Cancer Program Standards for Approved Cancer Programs. Therefore, it becomes even more important for pathologists to familiarize themselves with these documents. At the same time, the CAP cautions that use of the protocols other than for their intended educational purpose may involve additional considerations that are beyond the scope of this document.
The inclusion of a product name or service in a CAP publication should not be construed as an endorsement of such product or service, nor is failure to include the name of a product or service to be construed as disapproval.